Bank Of America Corp Sangamo Therapeutics, Inc Call Options Transaction History

Bank Of America Corp

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $869,465 - $1.16 Million	-96,500 Reduced 70.7%	40,000 $360,000
Q2 2021 Sep 13, 2021	BUY	$10.17 - $12.64 $1.39 Million - $1.73 Million	136,500 New	136,500 $1.63 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $294M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.